000 | 02231 a2200661 4500 | ||
---|---|---|---|
005 | 20250516122834.0 | ||
264 | 0 | _c20130418 | |
008 | 201304s 0 0 eng d | ||
022 | _a1432-1335 | ||
024 | 7 |
_a10.1007/s00432-012-1339-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPönisch, Wolfram | |
245 | 0 | 0 |
_aCombined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma. _h[electronic resource] |
260 |
_bJournal of cancer research and clinical oncology _cMar 2013 |
||
300 |
_a499-508 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aBendamustine Hydrochloride |
650 | 0 | 4 |
_aBoronic Acids _xadministration & dosage |
650 | 0 | 4 | _aBortezomib |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
650 | 0 | 4 |
_aNitrogen Mustard Compounds _xadministration & dosage |
650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRetrospective Studies |
700 | 1 | _aBourgeois, Malvina | |
700 | 1 | _aMoll, Barbara | |
700 | 1 | _aHeyn, Simone | |
700 | 1 | _aJäkel, Nadja | |
700 | 1 | _aWagner, Ina | |
700 | 1 | _aRohrberg, Robert | |
700 | 1 | _aHurtz, Hans-Jürgen | |
700 | 1 | _aSchmalfeld, Marion | |
700 | 1 | _aAßmann, Michael | |
700 | 1 | _aEdelmann, Thomas | |
700 | 1 | _aMohren, Martin | |
700 | 1 | _aHoffmann, Franz Albert | |
700 | 1 | _aBecker, Cornelia | |
700 | 1 | _aSchwarzer, Andreas | |
700 | 1 | _aSchönfelder, Uta | |
700 | 1 | _aZehrfeld, Thomas | |
700 | 1 | _aHensel, Gerald | |
700 | 1 | _aLöschcke, Kerstin | |
700 | 1 | _aKrahl, Rainer | |
700 | 1 | _aAli, Haifa Al | |
700 | 1 | _aNiederwieser, Dietger | |
773 | 0 |
_tJournal of cancer research and clinical oncology _gvol. 139 _gno. 3 _gp. 499-508 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00432-012-1339-3 _zAvailable from publisher's website |
999 |
_c22294399 _d22294399 |